Infections in Renal Transplant Treated with Belatacept

被引：0
|
作者：
Unterborn, R. [1 ]
Henao-Cordero, J. [2 ]
Scherger, S. [2 ]
Madinger, N. [2 ]
Barron, M. [2 ]
Benamu, E. [2 ]
机构：
[1] Univ Colorado, Internal Med, Denver, CO 80202 USA
[2] Univ Colorado, Infect Dis, Denver, CO 80202 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B203
引用
收藏
页码：S846 / S846
页数：1
相关论文
共 50 条
  • [41] Opportunistic Infections in Post Renal Transplant Patients Treated With Dexamethasone for COVID-19
    Morrison, Benjamin G.
    Fattah, Hasan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 324 - 324
  • [42] RATIONALE FOR BELATACEPT LESS-INTENSIVE (LI) REGIMEN IN RENAL TRANSPLANT RECIPIENTS
    Shen, Jinshan
    Gelb, Jeff S.
    Townsend, Robert M.
    Zhou, Zexun
    Pfister, Marc
    Harler, Mary Beth
    Kaul, Sanjeev
    TRANSPLANT INTERNATIONAL, 2011, 24 : 255 - 255
  • [43] Cytomegalovirus Infection In Renal Transplant Recipients Converted To Belatacept Following Alemtuzumab Induction
    Mikolay, J. J., Jr.
    Hatch, E.
    Churchwell, M.
    Sindhwani, P.
    Ekwenna, O.
    Malhotra, D.
    Ratnam, S.
    Kaw, D.
    Rees, M.
    Nadiminty, N.
    Rabets, J.
    Yadav, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S450 - S450
  • [44] Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?
    Mohamed H Sayegh
    Anil Chandraker
    Nature Clinical Practice Nephrology, 2006, 2 : 134 - 135
  • [45] BUDGET IMPACT ANALYSIS OF RENAL POST-TRANSPLANT PROPHYLAXIS WITH BELATACEPT IN COLOMBIA
    Alfonso-Cristancho, R.
    Diaz-Sotelo, O. D.
    Rosselli, D.
    Rueda, J. D.
    Garrido Lecca, S.
    VALUE IN HEALTH, 2013, 16 (07) : A697 - A697
  • [46] Is Belatacept Switch Safe in Renal Transplant Recipients With Donor-specific Antibodies?
    Suesal, Caner
    Morath, Christian
    TRANSPLANTATION, 2019, 103 (10) : 1984 - 1985
  • [47] Transient Utilization of Belatacept Facilitates Renal Recovery in Liver Transplant Recipients.
    Masters, B.
    Sparkes, T.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    LaMattina, J.
    Barth, R.
    TRANSPLANTATION, 2014, 98 : 753 - 754
  • [48] Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction
    Snyder, Heather S.
    Duhart, Benjamin T., Jr.
    Krauss, Amy G.
    Rao, Vinaya
    SAGE OPEN MEDICAL CASE REPORTS, 2016, 4
  • [49] Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?
    Sayegh, MH
    Chandraker, A
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (03): : 134 - 135
  • [50] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
12345